Opportunity
CanadaBuys #AB-2025-06713
Clinical Trial Research Organization Agent Services for ACT-GLOBAL Study
Posted
October 24, 2025
Respond By
October 31, 2025
Identifier
AB-2025-06713
NAICS
541715
This procurement opportunity involves the University of Calgary seeking a Clinical Trial Research Organization Agent for the ACT-GLOBAL clinical trial study. - Government Buyer: - University of Calgary - OEMs and Vendors: - Beijing Kutu Exhibition Co., Ltd. (BKEC) – acting as payment agent - Beijing Tiantan Hospital, Capital Medical University (BTH) – clinical trial sponsor - Products/Services Requested: - Clinical Trial Research Organization Agent services - Payment agent services for clinical trial support - Management of fund receipt and disbursement to clinical sites - Completion of government reporting requirements for the ACT-GLOBAL study - Unique or Notable Requirements: - BKEC is the only vendor capable due to its established relationship with BTH - No physical products are requested; the focus is on financial management and compliance reporting for clinical trial participation - Procurement is conducted under an Advance Contract Award Notice (ACAN)
Description
The University of Calgary has a Clinical Trial Support Agreement with Beijing Tiantan Hospital, Capital Medical University for enrollment and oversight of each Clinical Site to perform the Protocol. Beijing Kutu Exhibition Co., Ltd. acts as the payment agent for Beijing Tiantan Hospital, facilitating payments and disbursements related to the "ACT-GLOBAL" clinical trial study. BKEC will also complete required reporting to meet government requirements. Due to its established relationship, BKEC is the only vendor capable of providing these services.